Logo SymbolMenuClose menuSharePhone
EuroMed Foundation

Press Releases

The George Protocol is a unique, highly successful alternative cancer treatment, and is one of the keys to our unique approach to treating patients with cancer. We have successfully used Dr. George’s methods as the basis for cancer treatment.

Arizona Alternative Cancer Center Publishes New E-Book for Patients

EuroMed Foundation, an Arizona cancer center specializing in non-traditional therapies, has compiled its articles into a new, informative online resource. Phoenix, Arizona (October 2015) — EuroMed Foundation (www.euro-med.us) has published an e-book for patients, their families, and others interested in learning about the services provided by the Arizona alternative cancer center. According to the facility’s lead physicians, the book is…

Read more...

Breast Cancer Vaccine Shows How Interest in Immune System Is Growing

EuroMed Foundation, an Arizona cancer center, says the development of cancer vaccines increases awareness of the immune system’s role in treatment. Phoenix, Arizona (January 2015) — Physicians at EuroMed Foundation (www.euro-med.us), an Arizona cancer center that promotes holistic treatments, say vaccines that are making headlines lately highlight the immune system’s vital role in successfully treating cancer in a way that…

Read more...

Breast Cancer Breakthrough Draws Public Eye to Alternative Treatment

Researchers have discovered a new way to treat chemotherapy-resistant breast cancer by exploiting cancer cells’ proclivity for sugar, according to doctors at Arizona cancer center EuroMed who support the rise of treatment alternatives. Phoenix, Arizona (August 2013) — Researchers at the University of Southampton have announced a potential alternative for treating breast cancer that has become resistant to chemotherapy. The…

Read more...

Advances In Gerontology

Clinical records from individuals followed for 5years, 2000 to 2005, were reviewed. They were distrib-uted in 3 cohorts of ages ranging from 51 to 60, 61to 70, and 71 to 80 years, respectively. Each cohort in-cluded 2 groups of patients with diabetes type 2, onegroup treated with Metformin 850 mg/day, and the otherone without pharmacological treatment. In all groups,for each individual, the mean variation of glycosylatedhemoglobin, ferritin, lymphocyte count, total and sub-populations, was determined in blood using the mea-surement at the beginning and at the end of the 5-yearfollow-up. The number of all living individuals andcancer cases were also recorded in all groups at theend of the 5-year period. The results were consistentwith the reported significance as biomarkers of agingof: the increase of glycosylated hemoglobin and fer-ritin, the decrease of the number of total lymphocytesandCD8+T, and the increase ofT-Regulators. In thispreliminary observation, the protection of Metforminon the variations of aging biomarkers was associatedwith survival and decline of malignancy incidence.

Read more...

Aging And Social Change

In recent decades, knowledge about the inducing agents of geroprotection and the biomarkersfor measuring geroprotection has allowed scientists to explore their clinical significance andto evaluate their comparative activity.

Read more...

Contact form

Contact Us

Thank you for your inquiry!

We have received your inquiry and will get in touch with you shortly.

This filed is required!
This filed is required!
This filed is required!
This filed is required!